secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0001104659-23-078462
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 1.02, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MedTech Acquisition raises additional $22.3M in PIPE for TriSalus merger; amends merger agreement
--------------------------------------------------------------------------------

- Entered into subscription agreements for 2,229,500 shares of Series A Preferred at $10/share, aggregate $22,295,000.
- Combined with prior $17.855M, total PIPE proceeds of approximately $40.15M.
- Backstop Letter Agreement with Sponsor terminated as $2M commitment fulfilled by members via additional subscriptions.
- Third Amendment to Merger Agreement updates form of bylaws for post-merger TriSalus Life Sciences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923078462/0001104659-23-078462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923078462/tm2320024d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-078462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer